Annals of Surgical Oncology

, Volume 19, Issue 3, pp 941–947

Behavior of Serous Borderline Ovarian Tumors With and Without Micropapillary Patterns: Results of a French Multicenter Study

  • R. Fauvet
  • E. Demblocque
  • P. Morice
  • D. Querleu
  • E. Daraï
Gynecologic Oncology

DOI: 10.1245/s10434-011-2039-y

Cite this article as:
Fauvet, R., Demblocque, E., Morice, P. et al. Ann Surg Oncol (2012) 19: 941. doi:10.1245/s10434-011-2039-y

Abstract

Background

Behavior of serous borderline ovarian tumors with micropapillary patterns (MP-SBOT) is thought to be worse than those without micropapillary patterns, but few cohort studies have compared epidemiological characteristics, surgical management, and recurrence rates between these two groups.

Methods

In a French retrospective multicenter study of 475 borderline ovarian tumors (BOT) treated from 1990 to 2009, we studied patients with a serous BOT and treated after 2000 including 20 patients with and 77 patients without micropapillary patterns.

Results

Patients with MP-SBOT were younger (P = 0.01), often asymptomatic (P = 0.04), and with abnormal CA 125 serum levels (P = 0.04). Peritoneal implants were more frequently observed in these patients (P = 0.01); also, they underwent conservative treatment more frequently (P = 0.002), had a higher risk of misdiagnosis with invasive carcinoma by intraoperative histology (P < 0.05), and had more frequent restaging surgery (P = 0.001). No difference in recurrence was noted between the groups. No disease-related mortality was observed.

Conclusions

Patients with MP-SBOT represent a heterogeneous population in terms of presence of invasive peritoneal implants. Conservative surgery could be a suitable option for MP-SBOT patients without implants and who wish to conserve childbearing potential, without increasing the risk of recurrence.

Copyright information

© Society of Surgical Oncology 2011

Authors and Affiliations

  • R. Fauvet
    • 1
  • E. Demblocque
    • 1
  • P. Morice
    • 2
  • D. Querleu
    • 3
  • E. Daraï
    • 4
  1. 1.Department of Gynecology and Obstetrics, University Hospital of AmiensUniversity of Picardie, Jules VerneAmiensFrance
  2. 2.Department of Gynecologic Surgery, Gustave Roussy Cancer InstituteUniversity of Paris SudVillejuifFrance
  3. 3.Department of Surgery, Claudius Regaud Cancer InstituteUniversity Paul SabatierToulouseFrance
  4. 4.Department of Gynecology and Obstetrics, Tenon Hospital, AP-HP, Cancer EstUniversity of Paris VIParisFrance